CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.

Abstract:

:Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma characterized by short survival with current therapies, emphasizing the urgent need to develop new therapeutic approaches. Brentuximab vedotin (SGN-35) is an anti-CD30 monoclonal antibody (cAC10) conjugated by a protease-cleavable linker to a microtubule-disrupting agent, monomethyl auristatin E. Brentuximab vedotin is an effective treatment of relapsed CD30-expressing Classical Hodgkin and systemic anaplastic large cell lymphomas. Herein, we demonstrated that PEL cell lines and primary tumors express CD30 and thus may serve as potential targets for brentuximab vedotin therapy. In vitro treatment with brentuximab vedotin decreased cell proliferation, induced cell cycle arrest, and triggered apoptosis of PEL cell lines. Furthermore, in vivo brentuximab vedotin promoted tumor regression and prolonged survival of mice bearing previously reported UM-PEL-1 tumors as well as UM-PEL-3 tumors derived from a newly established and characterized Kaposi's sarcoma-associated herpesvirus- and Epstein-Barr virus-positive PEL cell line. Overall, our results demonstrate for the first time that brentuximab vedotin may serve as an effective therapy for PEL and provide strong preclinical indications for evaluation of brentuximab vedotin in clinical studies of PEL patients.

journal_name

Blood

journal_title

Blood

authors

Bhatt S,Ashlock BM,Natkunam Y,Sujoy V,Chapman JR,Ramos JC,Mesri EA,Lossos IS

doi

10.1182/blood-2013-01-481713

subject

Has Abstract

pub_date

2013-08-15 00:00:00

pages

1233-42

issue

7

eissn

0006-4971

issn

1528-0020

pii

blood-2013-01-481713

journal_volume

122

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Varying intensity of postremission therapy in acute myeloid leukemia.

    abstract::The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would improve the outcome. After uniform induction therapy, patients in com...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Cassileth PA,Lynch E,Hines JD,Oken MM,Mazza JJ,Bennett JM,McGlave PB,Edelstein M,Harrington DP,O'Connell MJ

    更新日期:1992-04-15 00:00:00

  • Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.

    abstract::Whether resveratrol, a component of red grapes, berries, and peanuts, could suppress the proliferation of multiple myeloma (MM) cells by interfering with NF-kappaB and STAT3 pathways, was investigated. Resveratrol inhibited the proliferation of human multiple myeloma cell lines regardless of whether they were sensitiv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-003988

    authors: Bhardwaj A,Sethi G,Vadhan-Raj S,Bueso-Ramos C,Takada Y,Gaur U,Nair AS,Shishodia S,Aggarwal BB

    更新日期:2007-03-15 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.

    abstract::Depletion of guanine nucleotide pools after inhibition of inosine monophosphate dehydrogenase (IMPDH) potently inhibits DNA synthesis by arresting cells in G1 and has been shown to induce the differentiation of cultured myeloid and erythroid cell lines, as well as chronic granulocytic leukemic cells after blast transf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Laliberté J,Yee A,Xiong Y,Mitchell BS

    更新日期:1998-04-15 00:00:00

  • Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

    abstract::Recent studies with long-term mouse marrow cultures have indicated the importance of the adherent layer as a primary reservoir of the most primitive stem cells, from which derivative stem cells and more differentiated progenitors are continuously generated. We have now examined the role of the adherent cell layer in l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulombel L,Eaves AC,Eaves CJ

    更新日期:1983-08-01 00:00:00

  • BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

    abstract::Clinical resistance to imatinib mesylate is commonly observed in patients with advanced Philadelphia chromosome- positive (Ph(+)) leukemias. Acquired resistance is typically associated with reactivation of BCR-ABL due to kinase domain mutations or gene amplification, indicating that BCR-ABL remains a viable target for...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1361

    authors: Gorre ME,Ellwood-Yen K,Chiosis G,Rosen N,Sawyers CL

    更新日期:2002-10-15 00:00:00

  • Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.

    abstract::All-trans retinoic acid (ATRA) is an essential component of the treatment of acute promyelocytic leukemia (APL), but the optimal timing and duration remain to be determined. Molecular characterization of this disease can refine the diagnosis and could be potentially useful in monitoring response to treatment. Patients...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Burnett AK,Grimwade D,Solomon E,Wheatley K,Goldstone AH

    更新日期:1999-06-15 00:00:00

  • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.

    abstract::We aimed to determine the prognostic impact of monosomal karyotype (MK) in acute myeloid leukemia (AML) in the context of the current World Health Organization (WHO) classification and to evaluate the outcome of MK(+) patients after allogeneic HSCT. Of 1058 patients with abnormal cytogenetics, 319 (30%) were MK MK(+)....

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-07-367508

    authors: Kayser S,Zucknick M,Döhner K,Krauter J,Köhne CH,Horst HA,Held G,von Lilienfeld-Toal M,Wilhelm S,Rummel M,Germing U,Götze K,Nachbaur D,Schlegelberger B,Göhring G,Späth D,Morlok C,Teleanu V,Ganser A,Döhner H,Schlenk

    更新日期:2012-01-12 00:00:00

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

    abstract::Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated. Patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005288

    authors: Voorhees PM,Kaufman JL,Laubach J,Sborov DW,Reeves B,Rodriguez C,Chari A,Silbermann R,Costa LJ,Anderson LD Jr,Nathwani N,Shah N,Efebera YA,Holstein SA,Costello C,Jakubowiak A,Wildes TM,Orlowski RZ,Shain KH,Cowan AJ,

    更新日期:2020-08-20 00:00:00

  • Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

    abstract::The t(11;14)(q13;q32) results in up-regulation of cyclin D1 and is the most common translocation detected in multiple myeloma, where it is also associated with a lymphoplasmacytic morphology. We performed an interphase fluorescent in situ hybridization (FISH) study to determine the clinical and biologic significance o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3735

    authors: Fonseca R,Blood EA,Oken MM,Kyle RA,Dewald GW,Bailey RJ,Van Wier SA,Henderson KJ,Hoyer JD,Harrington D,Kay NE,Van Ness B,Greipp PR

    更新日期:2002-05-15 00:00:00

  • Toward a stem cell gene therapy for breast cancer.

    abstract::Current approaches for treatment of late-stage breast cancer rarely result in a long-term cure. In part this is due to tumor stroma that prevents access of systemically or intratumorally applied therapeutics. We propose a stem cell gene therapy approach for controlled tumor stroma degradation that uses the pathophysio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-187237

    authors: Li Z,Liu Y,Tuve S,Xun Y,Fan X,Min L,Feng Q,Kiviat N,Kiem HP,Disis ML,Lieber A

    更新日期:2009-05-28 00:00:00

  • Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.

    abstract::Brentuximab vedotin induces an overall response rate of 75% in patients with relapsed/refractory Hodgkin lymphoma, but its impact on future allogeneic transplantation (allo-HCT) is not known. We retrospectively examined the records of 18 patients with relapsed/refractory Hodgkin lymphoma who were treated on brentuxima...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-03-418673

    authors: Chen R,Palmer JM,Thomas SH,Tsai NC,Farol L,Nademanee A,Forman SJ,Gopal AK

    更新日期:2012-06-28 00:00:00

  • Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.

    abstract::Anemia is a common clinical problem, and there is much interest in its role in promoting left ventricular hypertrophy through increasing cardiac workload. Normally, red blood cell production is adjusted through the regulation of erythropoietin (Epo) production by the kidney. One important cause of anemia is relative d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0605

    authors: Binley K,Askham Z,Iqball S,Spearman H,Martin L,de Alwis M,Thrasher AJ,Ali RR,Maxwell PH,Kingsman S,Naylor S

    更新日期:2002-10-01 00:00:00

  • Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.

    abstract::To obtain information relevant to the question of bone marrow transplantation, we examined the prognostic significance of disease features recorded at the time of diagnosis among 625 patients, aged 5 to 45, with Philadelphia chromosome-positive, nonblastic chronic granulocytic leukemia. The actuarial death rate for th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sokal JE,Baccarani M,Tura S,Fiacchini M,Cervantes F,Rozman C,Gomez GA,Galton DA,Canellos GP,Braun TJ

    更新日期:1985-12-01 00:00:00

  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

    abstract::Identification of prognostic factors for patients with relapsed/refractory Hodgkin lymphoma (HL) is essential for optimizing therapy with risk-adapted approaches. In our phase 2 study of positron emission tomography (PET)-adapted salvage therapy with brentuximab vedotin (BV) and augmented ifosfamide, carboplatin, and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-788877

    authors: Moskowitz AJ,Schöder H,Gavane S,Thoren KL,Fleisher M,Yahalom J,McCall SJ,Cadzin BR,Fox SY,Gerecitano J,Grewal R,Hamlin PA,Horwitz SM,Kumar A,Matasar M,Ni A,Noy A,Palomba ML,Perales MA,Portlock CS,Sauter C,Straus

    更新日期:2017-11-16 00:00:00

  • Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

    abstract::Pain is the leading cause of emergency department visits, hospitalizations, and daily suffering in individuals with sickle cell disease (SCD). The pathologic mechanisms leading to the perception of pain during acute RBC sickling episodes and development of chronic pain remain poorly understood and ineffectively treate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-327429

    authors: Hillery CA,Kerstein PC,Vilceanu D,Barabas ME,Retherford D,Brandow AM,Wandersee NJ,Stucky CL

    更新日期:2011-09-22 00:00:00

  • Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?

    abstract::Notch signaling pathway regulates many different events of embryonic and adult development; among them, Notch plays an essential role in the onset of hematopoietic stem cells and influences multiple maturation steps of developing lymphoid and myeloid cells. Deregulation of Notch signaling determines several human diso...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-08-376061

    authors: Nwabo Kamdje AH,Krampera M

    更新日期:2011-12-15 00:00:00

  • Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

    abstract::Memory stem T cells (TSCM) have been proposed as key determinants of immunologic memory. However, their exact contribution to a mounting immune response, as well as the mechanisms and timing of their in vivo generation, are poorly understood. We longitudinally tracked TSCM dynamics in patients undergoing haploidentica...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2014-11-608539

    authors: Cieri N,Oliveira G,Greco R,Forcato M,Taccioli C,Cianciotti B,Valtolina V,Noviello M,Vago L,Bondanza A,Lunghi F,Marktel S,Bellio L,Bordignon C,Bicciato S,Peccatori J,Ciceri F,Bonini C

    更新日期:2015-04-30 00:00:00

  • Germline CDKN2A mutation implicated in predisposition to multiple myeloma.

    abstract::Germline mutations of the CDKN2A (p16(INK4A)) tumor suppressor gene predispose patients to melanoma and pancreatic carcinoma. In contrast, mutations of the murine CDKN2A gene predispose BALB/c mice to pristane-induced plasmacytoma. We describe here a family in which a germline mutation of CDKN2A is present in 4 indivi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dilworth D,Liu L,Stewart AK,Berenson JR,Lassam N,Hogg D

    更新日期:2000-03-01 00:00:00

  • The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation.

    abstract::Collagen-induced activation of platelets in suspension leads to alpha(IIb)beta(3)-mediated outside-in signaling, granule release, thromboxane A2 (TxA2) production, and aggregation. Although much is known about collagen-induced platelet signaling, the roles of TxA2 production, adenosine diphosphate (ADP) and dense-gran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1363

    authors: Cho MJ,Liu J,Pestina TI,Steward SA,Thomas DW,Coffman TM,Wang D,Jackson CW,Gartner TK

    更新日期:2003-04-01 00:00:00

  • NMDA receptor-mediated regulation of human megakaryocytopoiesis.

    abstract::Identification of the regulatory inputs that direct megakaryocytopoiesis and platelet production is essential for the development of novel therapeutic strategies for the treatment of thrombosis and related hematologic disorders. We have previously shown that primary human megakaryocytes express the N-methyl-d-aspartat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3553

    authors: Hitchcock IS,Skerry TM,Howard MR,Genever PG

    更新日期:2003-08-15 00:00:00

  • Erythrocyte-endothelial cell adherence in sickle cell disorders.

    abstract::Detachment of individual sickle erythrocytes from cultured endothelial cell monolayers has been evaluated by a fluid-shearing technique in an effort to quantitate adherence at shear forces that would be anticipated in the in vivo circulation. Nonirreversibly sickled cells (non-ISC) were more adherent at normal oxygen ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Smith BD,La Celle PL

    更新日期:1986-11-01 00:00:00

  • ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.

    abstract::Cyclin dependent kinase (CDK) inhibitors, such as flavopiridol, demonstrate significant single-agent activity in chronic lymphocytic leukemia (CLL), but the mechanism of action in these nonproliferating cells is unclear. Here we demonstrate that CLL cells undergo autophagy after treatment with therapeutic agents, incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-400184

    authors: Mahoney E,Lucas DM,Gupta SV,Wagner AJ,Herman SE,Smith LL,Yeh YY,Andritsos L,Jones JA,Flynn JM,Blum KA,Zhang X,Lehman A,Kong H,Gurcan M,Grever MR,Johnson AJ,Byrd JC

    更新日期:2012-08-09 00:00:00

  • Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60.

    abstract::Plasma fibronectin (Fn) induces phagocytosis of C3b-opsonized sheep erythrocytes (EC3b) by human peripheral blood monocytes. However, Fn does not induce erythrophagocytosis of EC3b by human polymorphonuclear leukocytes (PMN), unless the PMN have been exposed to C5a or N-formyl-methionyl-leucyl-phenylalanine. Because o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pommier CG,O'Shea J,Chused T,Takahashi T,Ochoa M,Nutman TB,Bianco C,Brown EJ

    更新日期:1984-10-01 00:00:00

  • Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.

    abstract::The pathophysiology of microthrombocytopenia in the Wiskott-Aldrich syndrome (WAS) and its milder form, X-linked thrombocytopenia (XLT), is unclear. Although quantitative defects are correctable by splenectomy, residual platelet abnormalities are suggestive of intrinsic disturbances of production. In contrast to human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-03-1219

    authors: Sabri S,Foudi A,Boukour S,Franc B,Charrier S,Jandrot-Perrus M,Farndale RW,Jalil A,Blundell MP,Cramer EM,Louache F,Debili N,Thrasher AJ,Vainchenker W

    更新日期:2006-07-01 00:00:00

  • HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.

    abstract::Human immunodeficiency virus type 1 (HIV-1) uses the chemokine receptors CCR5 and CXCR4 as coreceptors for entry. It was recently demonstrated that HIV-1 glycoprotein 120 (gp120) elevated calcium and activated several ionic signaling responses in primary human macrophages, which are important targets for HIV-1 in vivo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.10.2909

    authors: Del Corno M,Liu QH,Schols D,de Clercq E,Gessani S,Freedman BD,Collman RG

    更新日期:2001-11-15 00:00:00

  • Age-dependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit.

    abstract::The white-spotting (Ws) locus of rats represents a 12-base deletion of the c-kit receptor tyrosine kinase. Homozygous Ws/Ws rats are deficient in melanocytes, mast cells, and erythrocytes. Although mice possessing two mutant alleles at the c-kit (W) locus, such as mice of W/Wv genotype, show severe anemia even in adul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morimoto M,Kasugai T,Tei H,Jippo-Kanemoto T,Kanakura Y,Kitamura Y

    更新日期:1993-12-01 00:00:00

  • Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.

    abstract::CD20 is a nonglycosylated 33 to 37 kD phosphoprotein involved in B-cell signaling that subserves important functions in the regulation of B-cell proliferation and differentiation. In addition, this B-cell surface antigen has been shown recently to be an effective target for immunotherapy of B-cell malignancies using c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shan D,Ledbetter JA,Press OW

    更新日期:1998-03-01 00:00:00

  • Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

    abstract::In Burkitt lymphoma/leukemia (BL), achievement of complete remission with first-line chemotherapy remains a challenging issue, as most patients who respond remain disease-free, whereas those refractory have few options of being rescued with salvage therapies. The mechanisms underlying BL chemoresistance and how it can...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268003

    authors: Richter-Larrea JA,Robles EF,Fresquet V,Beltran E,Rullan AJ,Agirre X,Calasanz MJ,Panizo C,Richter JA,Hernandez JM,Roman-Gomez J,Prosper F,Martinez-Climent JA

    更新日期:2010-10-07 00:00:00

  • Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo.

    abstract::During the inflammatory response, granulocytes and other leukocytes adhere to and emigrate from small venules. Before firm attachment, leukocytes are observed rolling slowly along the endothelium in venules of most tissues accessible to intravital microscopy. The molecular mechanism underlying this early type of leuko...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ley K,Gaehtgens P,Fennie C,Singer MS,Lasky LA,Rosen SD

    更新日期:1991-06-15 00:00:00